Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
orelabrutinib (1 trial)
sintilimab (1 trial)
tislelizumab (1 trial)
dental pulp mesenchymal stem cells (1 trial)
Pneumonia (Phase 1)
Trials (2 total)
Trial APIs (4 total)